Pulmonology

Doç. Dr. Nalan Ogan

Doctor and researcher Ankara Etlik Şehir Hastanesi Ankara
PneumoniaCOVID-19
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Pneumonia 3 publications
    Source: OpenAlex / PubMed MeSHView publications
  • COVID-19 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPulmonologysaglik.gov.trFrom source
  • InstitutionAnkara Etlik Şehir Hastanesisaglik.gov.trFrom source
  • Area of workPneumoniaExtracted from 3 publications · Model version —From source
  • Publications78 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0001-5232-3803ORCIDFrom source
  • Last synchronised7 November 2026 00:02https://etliksehir.saglik.gov.tr/TR-863757/klinik-doktorlarimiz.html#nalan-ogansaglik.gov.tr

Scientific work

Publications on Pneumonia

78 publications
Publications by year Most: 13, in 2020
  1. 2015: 2 publications
  2. 2016: 0 publications
  3. 2017: 5 publications
  4. 2018: 10 publications
  5. 2019: 11 publications
  6. 2020: 13 publications
  7. 2021: 8 publications
  8. 2022: 8 publications
  9. 2023: 2 publications
  10. 2024: 4 publications
  11. 2025: 6 publications
  12. 2026: 9 publications

  1. Evaluation of Microplastic Density in Bronchoalveolar Lavage Fluid of Newly Diagnosed Lung Cancer Patients: A Prospective Observational Controlled Study

    2026

    DOI 10.2139/ssrn.6883835 Source: ORCID

  2. PREVALENCE AND CLINICAL CHARACTERISTICS OF LUNG CANCER IN ELDERY PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

    Turkish Journal of Geriatrics, 2026

    DOI 10.29400/tjgeri.2026.487 Open-access full textSource: ORCID

  3. Evaluation of Microplastic Density in Bronchoalveolar Lavage Fluid of Newly Diagnosed Lung Cancer Patients: A Prospective Observational Controlled Study

    Research Square, 2026

    DOI 10.21203/rs.3.rs-10095928/v1 Open-access full textSource: OpenAlex

  4. Predictors of Diffusion Capacity through Cardiopulmonary Exercise Testing Parameters in Patients with Fibrotic Interstitial Lung Disease: A Pilot Study

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa2692 Source: OpenAlex

  5. Is Heart Rate Recovery an Independent Marker of Exacerbation Risk in Stable COPD?

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa4316 Source: OpenAlex

  6. Serum paraoxonase-1 as a marker of oxidative stress and pulmonary dysfunction in sarcoidosis: association with disease activity and prognostic potential

    Frontiers in Immunology, 2026

    DOI 10.3389/fimmu.2025.1731991 PMID 41601643 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  7. Inhaler Adherence and Treatment Behaviors in COPD: A Study from Both Sides of the Aegean Sea

    Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2026

    DOI 10.1177/19412711261452804 PMID 42187273 Source: OpenAlex

  8. Splenic Silicosis Accompanying Chronic Complicated Silicosis: A Rare Systemic Manifestation of Silica Exposure – A Case Report

    Indian Journal of Occupational and Environmental Medicine, 2026

    DOI 10.4103/ijoem.ijoem_278_25 PMID 42872257 Open-access full textSource: OpenAlex

  9. Clinical characteristics and mortality risk factors in COVID-19 patients with pulmonary embolism

    Journal of Pulmonology and Intensive Care, 2026

    DOI 10.51271/jopic-0090 Open-access full textSource: OpenAlex

  10. Association between idiopathic pulmonary fibrosis and lung cancer

    Journal of Pulmonology and Intensive Care, 2025

    DOI 10.51271/jopic-0049 Open-access full textSource: ORCID

View all 78 publications